TriSalus Life Sciences (TLSI) EBT Margin (2022 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly EBT Margin of 17.34% for Q1 2026, up 13046.0% year-over-year from N/an in Q1 2025, and up 123.48% quarter-over-quarter from 73.86% in Q4 2025.
TriSalus Life Sciences (TLSI) EBT Margin (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' EBT Margin history runs 5 years deep, the most recent figure standing at 17.34% for Q1 2026.
- In Q1 2026, EBT Margin rose 13046.0% year-over-year to 17.34%; the TTM figure through Mar 2026 stood at 60.84% (up 2381.0% YoY), while the FY2025 annual figure was 86.86%, up 1520.0% from the prior year.
- EBT Margin for Q1 2026 stood at 17.34%, up from 73.86% in the prior quarter.
- The five-year high for EBT Margin was 17.34% in Q1 2026, with the low at 698.57% in Q4 2022.
- The 5-year median for EBT Margin is 113.12% (2025), against an average of 192.7%.
- The sharpest annual moves came in 2024 and 2025: EBT Margin surged 50056 bps in 2024, then tumbled 6074 bps in 2025.
- TriSalus Life Sciences' EBT Margin stood at 698.57% in 2022, then rose by 11 bps to 622.93% in 2023, then surged by 80 bps to 122.37% in 2024, then jumped by 40 bps to 73.86% in 2025, then soared by 123 bps to 17.34% in 2026.
- Business Quant data shows TLSI's EBT Margin at 17.34% in Q1 2026, 73.86% in Q4 2025, and 93.43% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 18.32% |
| 10 | TriSalus Life Sciences | 307.22 Mn | 260.94 Mn | 9.90 Mn | -80.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -80.50% |
| Mar 31, 2026 | 17.34% |
| Dec 31, 2025 | -73.86% |
| Sep 30, 2025 | -93.43% |
| Jun 30, 2025 | -73.94% |
| Mar 31, 2025 | -113.12% |
| Dec 31, 2024 | -122.37% |
| Sep 30, 2024 | -32.68% |
| Jun 30, 2024 | -58.73% |
| Mar 31, 2024 | -204.48% |
| Dec 31, 2023 | -622.93% |
| Sep 30, 2023 | -27.44% |
| Jun 30, 2023 | -302.71% |
| Mar 31, 2023 | -277.25% |
| Dec 31, 2022 | -698.57% |
| Sep 30, 2022 | -206.30% |